ClinicalTrials.Veeva

Menu

Methotrexate in Retinal Detachment With Proliferative Vitreoretinopathy

B

Benha University

Status

Completed

Conditions

Retinal Detachment

Treatments

Procedure: parsplana vitrectomy
Procedure: adjunctive use of Methotrexate

Study type

Interventional

Funder types

Other

Identifiers

NCT07058337
Methorexate in PVR

Details and patient eligibility

About

The aim of this study is to evaluate the efficacy and safety of intraocular methotrexate (MTX) in preventing and managing proliferative vitreoretinopathy (PVR) in patients undergoing retinal detachment surgery

Full description

Patients will be randomized into two groups if clinical evidence of PVR is detected at the time of surgery, utilizing a computer-generated list for randomization. All surgeries will be conducted by the same surgeon to maintain consistency in technique.

Intervention Groups:

  1. Group 1 (PPV Alone): Patients in this group will undergo pars plana vitrectomy (PPV) only.

Group 2 (PPV with Methotrexate): Patients in this group will receive complete PPV along with adjunctive intravitreal methotrexate.

Enrollment

20 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18 years and older.
  • Diagnosed with RRD with clinical signs of PVR.
  • No history of prior ocular surgeries for RRD or PVR.

Exclusion criteria

  • Patients with other retinal diseases (e.g., diabetic retinopathy or retinal vascular occlusions).
  • Individuals with significant systemic illnesses that could influence surgical outcomes.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

20 participants in 2 patient groups

Group 1 (PPV Alone)
Active Comparator group
Description:
Patients in this group will undergo pars plana vitrectomy (PPV) only.
Treatment:
Procedure: parsplana vitrectomy
Group 2 (PPV with Methotrexate)
Active Comparator group
Description:
Patients in this group will receive complete PPV along with adjunctive intravitreal methotrexate
Treatment:
Procedure: adjunctive use of Methotrexate
Procedure: parsplana vitrectomy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems